Version imprimable
Bonjour il semblerait qu'une nouvelle technologie soit mise au point outre atlantique dans le traitement des mycoses unguéales. Il semblerait même que cela soit efficace et indolore...
Qu'en est il de l'adaptation de ce traitement sur le marché français?
[url=http://santelog.net/modules/connaissances/actualite-sante-onychomycose-un-seul-rayon-laser-contre-la-mycose-des-ongles_1175.htm]Actu sant : ONYCHOMYCOSE : Un seul RAYON LASER contre la mycose des ongles[/url]
Voici le lien concernant cette technologie egalement présente en Allemagne et en Grande Bretagne... Elle donnerait des resultats très probants évitant ainsi de prendre un traitement oral pendant de nombreux mois..
Il n'existe pas pour l'instant d'études sérieuses qui précise l'intérêt de cette technique et je ne crois pas en ce qui me concerne qu'elle est le moindre intérêt.
[URL="http://www.ncbi.nlm.nih.gov/pubmed/21250792#"]J Cosmet Laser Ther.[/URL] 2011 Feb;13(1):2-5. Epub 2011 Jan 21.
[h=1]Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser.[/h][URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hochman%20LG%22%5BAuthor%5D"]Hochman LG[/URL].
[h=3]Source[/h]Morristown Dermatology, 290 Madison Avenue, Morristown, 07960, USA. [email]Derm@morristowndermatology.com[/email]
[h=3]Abstract[/h]Onychomycosis is a common disorder of the nails. Treatment modalities include oral and topical antifungals, surgical treatment or a combination of these therapies. Cure rates remain low with relatively high relapse rates seen after successful treatment. The purpose of this study was to evaluate the treatment of onychomycosis using a novel 0.65-millisecond (ms) pulsed 1064-nm laser. Eight subjects were treated over two to three sessions spaced at least 3 weeks apart. Of the eight subjects evaluated, seven had negative post-treatment cultures after the second or third session. Treatments were well tolerated by all subjects. These data suggest that treatment of onychomycosis with a 0.65-ms pulsed Nd:YAG 1064-nm laser should be studied further to determine the long-term clinical and microbiologic effect. The optimal number of treatment sessions for each patient needs to be determined.
[COLOR=#575757][URL="http://www.ncbi.nlm.nih.gov/pubmed/22052283#"]J Drugs Dermatol.[/URL] 2011 Sep 1;10(9):1074-5.
[h=1]Onychomycosis: is there a role for lasers?[/h][URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bergstrom%20KG%22%5BAuthor%5D"]Bergstrom KG[/URL].
[h=3]Source[/h]Pacific Medical Centers, Seattle, WA.
[/COLOR]